세계의 단백질 칩 시장 보고서(2025년)
Protein Chip Global Market Report 2025
상품코드 : 1825882
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,469,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,350,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,232,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

단백질 칩 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 22억 7,000만 달러로 성장할 것이며, 연평균 7.1%의 성장률을 보일 것입니다. 예측 기간의 성장은 맞춤형 의료, 차세대 단백질 칩 기술, 오믹스 기술과의 통합, 신흥 시장에서의 채택, 디지털 헬스 및 웨어러블 기기로의 전환에 대한 수요 증가에 기인합니다. 예측 기간의 주요 동향으로는 소형화 및 다중화, 인공지능(AI) 및 머신러닝과의 통합, 현장진단(POCT) 애플리케이션, 새로운 질병 영역으로의 확장, 맞춤화 및 개인화 등을 꼽을 수 있습니다.

향후 5년간 7.1%의 성장률 전망은 지난번 예측보다 0.4% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 이스라엘과 대만에서 개발된 마이크로어레이 칩과 로봇 스팟팅 시스템의 가격을 급등시켜 신약 개발 지연과 바이오테크놀러지 스타트업 비용 상승을 가져와 미국의 단백질체학 연구를 저해할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

단백질 칩 시장은 환자 개개인의 필요에 따라 약물 요법이나 치료법을 맞춤화하는 맞춤형 의료에 대한 수요 증가로 성장할 태세를 갖추고 있습니다. 이 접근법은 '오믹스' 기술, 유전학, 데이터 통합의 발전으로 주목받고 있으며, 개별화된 치료와 예방 조치의 중요성이 강조되고 있습니다. 단백질 칩은 종합적인 단백질체 분석을 가능하게 하고, 바이오마커 발견을 돕고, 의약품 개발에 대한 이해를 높이고, 맞춤형 치료 전략 수립을 촉진함으로써 맞춤형 의료의 발전에 중요한 역할을 하고 있습니다. 예를 들어, 2022년 10월 현재 개인맞춤의료연합은 75,000개 이상의 유전자 검사 제품과 암, 희귀질환, 만성질환 등 다양한 증상에 사용할 수 있는 300개의 맞춤형 의약품을 보고하고 있습니다. 또한, 이 단체에 따르면, 2022년에는 새로 승인된 치료제의 34%에 해당하는 12종의 맞춤형 치료제가 새롭게 승인될 것으로 예상했습니다. 그 결과, 맞춤형 의료에 대한 수요 증가가 단백질 칩 시장 확대의 주요 요인으로 작용하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오(금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 신종 코로나바이러스 감염증과 회복이 시장에 미치는 영향을 포함) 4.1.관세 전쟁과 보호무역주의별 공급망에 대한 영향

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

A protein chip serves as a high-throughput analytical instrument employed for the comprehensive examination and assessment of protein interactions, functions, and activities on a large scale. Its operation entails several steps, including the immobilization of proteins onto a solid surface, the probing with samples or molecules of interest, and the subsequent detection and analysis of the ensuing interactions or signals.

The primary offerings within the protein chip market encompass lab-on-chip systems, integrated setups, arrayers, and microarray systems. Lab-on-chip technology effectively condenses and merges multiple laboratory functionalities onto a singular chip, facilitating the swift and effective analysis of biological specimens. This technology encompasses a range of methodologies such as analytical microarrays, functional protein microarrays, and reverse phase protein microarrays, all of which find application in diverse fields including diagnostics, proteomics, and antibody characterization. These solutions cater to a broad spectrum of end-users, including hospitals and clinics, academic and research institutions, diagnostic laboratories, as well as pharmaceutical and biotechnology enterprises.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The protein chip market research report is one of a series of new reports from The Business Research Company that provides protein chip market statistics, including the protein chip industry global market size, regional shares, competitors with a protein chip market share, detailed protein chip market segments, market trends, and opportunities, and any further data you may need to thrive in the protein chip industry. This protein chip research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The protein chip market size has grown strongly in recent years. It will grow from $1.61 billion in 2024 to $1.73 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to the rise in proteomics research, increasing cancer incidence rates, technological innovations, expanding applications in clinical diagnostics, increasing focus on biomarker discovery, and growing demand for high-throughput protein analysis.

The protein chip market size is expected to see strong growth in the next few years. It will grow to $2.27 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to rising demand for personalized medicine, next-generation protein chip technologies, integration with omics technologies, adoption in emerging markets, and a shift towards digital health and wearable devices. Major trends in the forecast period include miniaturization and multiplexing, integration with artificial intelligence (AI) and machine learning, point-of-care testing (POCT) applications, expansion into new disease areas, and customization and personalization.

The forecast of 7.1% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. proteomics research by inflating prices of microarray chips and robotic spotting systems developed in Israel and Taiwan, resulting in delayed drug discovery and higher biotech startup costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The protein chip market is poised for growth due to the increasing demand for personalized medicine, which involves tailoring medications and interventions to meet individual patient needs. This approach has gained prominence thanks to advancements in 'omics' technology, genetics, and data integration, emphasizing the importance of personalized treatments and preventive measures. Protein chips play a crucial role in advancing personalized medicine by enabling comprehensive proteomic analysis, aiding biomarker discovery, enhancing drug development understanding, and facilitating the creation of personalized therapeutic strategies. For example, as of October 2022, the Personalized Medicine Coalition reported over 75,000 genetic testing products and 300 personalized medicines available for various conditions, including cancer, rare diseases, and chronic illnesses. Additionally, in 2022, 12 new customized medications were approved, representing 34% of all newly approved treatments, according to the same organization. Consequently, the growing demand for personalized medicine is a key driver for the expansion of the protein chip market.

Leading companies in the protein chip market are focusing on product innovation to strengthen their market position. One such innovation is the development of automated parallel capillary electrophoresis systems, which are advanced instruments for high-throughput separation and analysis of biomolecules such as proteins and nucleic acids. For instance, in January 2024, Agilent Technologies Inc. launched the ProteoAnalyzer system, an automated parallel capillary electrophoresis device designed for protein analysis. This system features state-of-the-art algorithms for precise protein identification and characterization, enabling researchers to explore complex biological systems with unparalleled accuracy and efficiency. It also offers enhanced data visualization tools for intuitive result interpretation and seamless integration with existing workflows, ensuring smooth adoption and increased productivity in proteomics laboratories.

In March 2023, Spectrum Solutions LLC acquired MDx Lab Alimetrix and Array Maker Microarrays Inc., aiming to expand its portfolio of laboratory products and testing capabilities. This acquisition strengthens Spectrum's position in the diagnostics market, with Array Maker Microarrays Inc. providing protein and DNA microarray assays using microarray technology for gene identification.

Major companies operating in the protein chip market are Thermo Fisher Scientific Inc., GE Healthcare LLC, Roche Diagnostics GmbH, Agilent Technologies Inc., Illumina Inc., Sigma-Aldrich Corporation (Merck), PerkinElmer Inc., Shimadzu Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Surmodics Inc., Quotient Limited, OriGene Technologies Inc., RayBiotch Inc., Sengenics Corporation Pte Ltd., Gyros Protein Technologies AB, Innova Biosciences Limited, Innopsys S.A., CDI Laboratories Inc., Microarrays Inc., Full Moon BioSystems Inc., Arrayit Corporation, Biotech Support Group LLC

North America was the largest region in the global protein chip market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the protein chip market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The protein chip market includes revenues earned by entities by providing services such as protein expression profiling, biomarker discovery, post-translational modification (PTM) analysis, quantitative and qualitative proteomics, and enzyme activity assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein chip market consists of sales of antibody arrays, protein arrays, peptide arrays, and full moon biosystems protein arrays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Protein Chip Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on protein chip market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for protein chip ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The protein chip market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Protein Chip Market Characteristics

3. Protein Chip Market Trends And Strategies

4. Protein Chip Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Protein Chip Growth Analysis And Strategic Analysis Framework

6. Protein Chip Market Segmentation

7. Protein Chip Market Regional And Country Analysis

8. Asia-Pacific Protein Chip Market

9. China Protein Chip Market

10. India Protein Chip Market

11. Japan Protein Chip Market

12. Australia Protein Chip Market

13. Indonesia Protein Chip Market

14. South Korea Protein Chip Market

15. Western Europe Protein Chip Market

16. UK Protein Chip Market

17. Germany Protein Chip Market

18. France Protein Chip Market

19. Italy Protein Chip Market

20. Spain Protein Chip Market

21. Eastern Europe Protein Chip Market

22. Russia Protein Chip Market

23. North America Protein Chip Market

24. USA Protein Chip Market

25. Canada Protein Chip Market

26. South America Protein Chip Market

27. Brazil Protein Chip Market

28. Middle East Protein Chip Market

29. Africa Protein Chip Market

30. Protein Chip Market Competitive Landscape And Company Profiles

31. Protein Chip Market Other Major And Innovative Companies

32. Global Protein Chip Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Protein Chip Market

34. Recent Developments In The Protein Chip Market

35. Protein Chip Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기